In silicoanalysis of protein/peptide-based inhalers against SARS-CoV-2

被引：3
|
作者：
Salman, Saad [1 ]
Shah, Fahad Hassan [2 ]
Chaudhry, Maham [1 ]
Tariq, Muniba [3 ]
Akbar, Muhammad Yasir [4 ]
Adnan, Muhammad [1 ]
机构：
[1] Univ Lahore, Dept Pharm, Islamabad Campus, Islamabad 44000, Federal, Pakistan
[2] Univ Peshawar, Ctr Biotechnol & Microbiol, Khyber Pakhtunkhwa, Pakistan
[3] Univ Lahore, Diet & Nutr Sci, Islamabad Campus, Islamabad 44000, Federal, Pakistan
[4] Quaid i Azam Univ, Dept Bioinformat, Islamabad 44000, Federal, Pakistan
来源：
FUTURE VIROLOGY | 2020年 / 15卷 / 09期
关键词：
COVID-19; dornase-alfa; inhalers; monoclonal antibody; short-palate-lung and nasal-epithelial clone-1-derived peptides; DELIVERY; LUNG;
D O I：
10.2217/fvl-2020-0119
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Aim:Peptide/protein-based inhalers are excessively used to treat respiratory disorders. The molecular docking was performed for these inhalers including human neutralizing S230 light chain-antibody (monoclonal antibodies [mAbs]), alpha-1-antitrypsin (AAT), short-palate-lung and nasal-epithelial clone-1-derived peptides (SPLUNC1) and dornase-alfa (DA) against spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to assess their inhibitory activity.Materials & methods:HawkDock was used to dock these biologics against SARS-CoV-2 spike-glycoprotein.Results:Results showed that DA, AAT and mAb were quite active against spike glycoprotein with a binding free energy of -26.35 and -22.94 kcal/mol.Conclusion:mAB and AAT combined with DA can be used in the treatment of coronavirus disease of 2019 as a potential anti-SARS-CoV-2 agent.
引用
收藏
页码：557 / 564
页数：8
相关论文
共 50 条
  • [41] SARS-CoV-2 spike protein capture by peptide functionalized networks
    Rahman, Monica S.
    Rajawasam, Chamoni W. H.
    Watuthanthrige, Nethmi De Alwis
    Sparks, Jessica L.
    Page, Richard C.
    Konkolewicz, Dominik
    JOURNAL OF POLYMER SCIENCE, 2023, 61 (05) : 391 - 397
  • [42] Study of fusion peptide release for the spike protein of SARS-CoV-2
    Yu, Jie
    Zhang, Zhi-Wei
    Yang, Han-Yu
    Liu, Chong-Jin
    Lu, Wen-Cai
    RSC ADVANCES, 2023, 13 (25) : 16970 - 16983
  • [43] Application of the Crystal Structure of the SARS-CoV-2 Spike Protein for the Development of a Peptide Vaccine against Virus
    Ivanovsky, A. S.
    Kolesnikov, I. A.
    Kordonskaya, Yu. V.
    Ermakov, A. V.
    Marchenkova, M. A.
    Timofeev, V. I.
    Pisarevsky, Yu. V.
    Dyakova, Yu. A.
    Kovalchuk, M. V.
    CRYSTALLOGRAPHY REPORTS, 2023, 68 (06) : 951 - 954
  • [44] Application of the Crystal Structure of the SARS-CoV-2 Spike Protein for the Development of a Peptide Vaccine against Virus
    A. S. Ivanovsky
    I. A. Kolesnikov
    Yu. V. Kordonskaya
    A. V. Ermakov
    M. A. Marchenkova
    V. I. Timofeev
    Yu. V. Pisarevsky
    Yu. A. Dyakova
    M. V. Kovalchuk
    Crystallography Reports, 2023, 68 : 951 - 954
  • [45] A VACCINE AGAINST SARS-COV-2
    Passi, Gouri Rao
    INDIAN PEDIATRICS, 2020, 57 (06) : 593 - 593
  • [46] The Development of Epitope-Based Recombinant Protein Vaccines against SARS-CoV-2
    Khalid, Kanwal
    Lim, Hui Xuan
    Hwang, Jung Shan
    Poh, Chit Laa
    AAPS JOURNAL, 2024, 26 (05):
  • [47] Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
    Bates, Timothy A.
    Weinstein, Jules B.
    Farley, Scotland
    Leier, Hans C.
    Messer, William B.
    Tafesse, Fikadu G.
    CELL REPORTS, 2021, 34 (07):
  • [48] Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors
    Previti, Santo
    Ettari, Roberta
    Calcaterra, Elsa
    Di Maro, Salvatore
    Hammerschmidt, Stefan J.
    Mueller, Christin
    Ziebuhr, John
    Schirmeister, Tanja
    Cosconati, Sandro
    Zappala, Maria
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 247
  • [49] In silico design of multi-epitope-based peptide vaccine against SARS-CoV-2 using its spike protein
    Mitra, Debarghya
    Pandey, Janmejay
    Jain, Alok
    Swaroop, Shiv
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (11): : 5189 - 5202
  • [50] Structure and Function of the SARS-CoV-2 6-HB Fusion Core and Peptide-based Fusion Inhibitors: A Review
    Liang, Guodong
    Li, Yue
    Li, Ruijuan
    Ma, Yuheng
    Na, Heiya
    CURRENT MEDICINAL CHEMISTRY, 2023,
12345